Trial Outcomes & Findings for Clinical Assessment of a Daily Wear Monthly Replacement Soft Silicone Hydrogel Contact Lens (NCT NCT04476784)

NCT ID: NCT04476784

Last Updated: 2021-10-26

Results Overview

Visual acuity (VA) was collected for each eye individually with study lenses in place at a distance of 4 meters using a letter chart. VA was measured in logarithm minimum angle of resolution (logMAR). On Day 30, VA was assessed after 6-8 hours of wear. A logMAR value of 0 equates to 20/20 Snellen visual acuity (normal distance eyesight), with a lower logMAR value indicating better visual acuity. No formal hypothesis testing was planned.

Recruitment status

COMPLETED

Study phase

NA

Target enrollment

66 participants

Primary outcome timeframe

Day 1, Day 30 after 6-8 hours of wear, each product

Results posted on

2021-10-26

Participant Flow

Subjects were enrolled at 5 investigative sites located in the United States.

This reporting group includes all subjects/eyes (66/132) exposed to any study lenses evaluated in this study as treated (Safety Analysis Set)

Unit of analysis: eyes

Participant milestones

Participant milestones
Measure
LID018869, Then Biofinity
Lehfilcon A contact lenses worn first, followed by comfilcon A contact lenses, as randomized. Each product was worn in both eyes during waking hours only for at least 5 days per week over a 30-day period. CLEAR CARE was used for nightly cleaning and disinfection.
Biofinity, Then LID018869
Comfilcon A contact lenses worn first, followed by lehfilcon A contact lenses, as randomized. Each product was worn in both eyes during waking hours only for at least 5 days per week over a 30-day period. CLEAR CARE was used for nightly cleaning and disinfection.
First Wear Period (30 Days ± 2 Days)
STARTED
31 62
35 70
First Wear Period (30 Days ± 2 Days)
COMPLETED
30 60
35 70
First Wear Period (30 Days ± 2 Days)
NOT COMPLETED
1 2
0 0
Second Wear Period (30 Days ± 2 Days)
STARTED
30 60
35 70
Second Wear Period (30 Days ± 2 Days)
COMPLETED
30 60
35 70
Second Wear Period (30 Days ± 2 Days)
NOT COMPLETED
0 0
0 0

Reasons for withdrawal

Reasons for withdrawal
Measure
LID018869, Then Biofinity
Lehfilcon A contact lenses worn first, followed by comfilcon A contact lenses, as randomized. Each product was worn in both eyes during waking hours only for at least 5 days per week over a 30-day period. CLEAR CARE was used for nightly cleaning and disinfection.
Biofinity, Then LID018869
Comfilcon A contact lenses worn first, followed by lehfilcon A contact lenses, as randomized. Each product was worn in both eyes during waking hours only for at least 5 days per week over a 30-day period. CLEAR CARE was used for nightly cleaning and disinfection.
First Wear Period (30 Days ± 2 Days)
Withdrawal by Subject
1
0

Baseline Characteristics

Clinical Assessment of a Daily Wear Monthly Replacement Soft Silicone Hydrogel Contact Lens

Baseline characteristics by cohort

Baseline characteristics by cohort
Measure
LID018869, Then Biofinity
n=31 Participants
Lehfilcon A contact lenses worn first, followed by comfilcon A contact lenses, as randomized. Each product was worn in both eyes during waking hours only for at least 5 days per week over a 30-day period. CLEAR CARE was used for nightly cleaning and disinfection.
Biofinity, Then LID018869
n=35 Participants
Comfilcon A contact lenses worn first, followed by lehfilcon A contact lenses, as randomized. Each product was worn in both eyes during waking hours only for at least 5 days per week over a 30-day period. CLEAR CARE was used for nightly cleaning and disinfection.
Total
n=66 Participants
Total of all reporting groups
Age, Continuous
32.6 years
STANDARD_DEVIATION 8.0 • n=5 Participants
33.7 years
STANDARD_DEVIATION 8.7 • n=7 Participants
33.2 years
STANDARD_DEVIATION 8.3 • n=5 Participants
Sex: Female, Male
Female
24 Participants
n=5 Participants
28 Participants
n=7 Participants
52 Participants
n=5 Participants
Sex: Female, Male
Male
7 Participants
n=5 Participants
7 Participants
n=7 Participants
14 Participants
n=5 Participants
Ethnicity (NIH/OMB)
Hispanic or Latino
0 Participants
n=5 Participants
0 Participants
n=7 Participants
0 Participants
n=5 Participants
Ethnicity (NIH/OMB)
Not Hispanic or Latino
31 Participants
n=5 Participants
35 Participants
n=7 Participants
66 Participants
n=5 Participants
Ethnicity (NIH/OMB)
Unknown or Not Reported
0 Participants
n=5 Participants
0 Participants
n=7 Participants
0 Participants
n=5 Participants
Race (NIH/OMB)
American Indian or Alaska Native
0 Participants
n=5 Participants
0 Participants
n=7 Participants
0 Participants
n=5 Participants
Race (NIH/OMB)
Asian
0 Participants
n=5 Participants
0 Participants
n=7 Participants
0 Participants
n=5 Participants
Race (NIH/OMB)
Native Hawaiian or Other Pacific Islander
0 Participants
n=5 Participants
0 Participants
n=7 Participants
0 Participants
n=5 Participants
Race (NIH/OMB)
Black or African American
1 Participants
n=5 Participants
0 Participants
n=7 Participants
1 Participants
n=5 Participants
Race (NIH/OMB)
White
30 Participants
n=5 Participants
34 Participants
n=7 Participants
64 Participants
n=5 Participants
Race (NIH/OMB)
More than one race
0 Participants
n=5 Participants
0 Participants
n=7 Participants
0 Participants
n=5 Participants
Race (NIH/OMB)
Unknown or Not Reported
0 Participants
n=5 Participants
1 Participants
n=7 Participants
1 Participants
n=5 Participants
Region of Enrollment
United States
31 participants
n=5 Participants
35 participants
n=7 Participants
66 participants
n=5 Participants

PRIMARY outcome

Timeframe: Day 1, Day 30 after 6-8 hours of wear, each product

Population: Full Analysis Set: All randomized subjects who are exposed to any study lenses evaluated in this study.

Visual acuity (VA) was collected for each eye individually with study lenses in place at a distance of 4 meters using a letter chart. VA was measured in logarithm minimum angle of resolution (logMAR). On Day 30, VA was assessed after 6-8 hours of wear. A logMAR value of 0 equates to 20/20 Snellen visual acuity (normal distance eyesight), with a lower logMAR value indicating better visual acuity. No formal hypothesis testing was planned.

Outcome measures

Outcome measures
Measure
LID018869
n=132 eyes
Lehfilcon A contact lenses worn in both eyes during waking hours only for at least 5 days per week over a 30-day period. CLEAR CARE was used for nightly cleaning and disinfection.
Biofinity
n=130 eyes
Comfilcon A contact lenses worn in both eyes during waking hours only for at least 5 days per week over a 30-day period. CLEAR CARE was used for nightly cleaning and disinfection.
Mean Distance Visual Acuity (logMAR) With Study Lenses
Day 1
-0.11 logMAR
Standard Deviation 0.08
-0.13 logMAR
Standard Deviation 0.08
Mean Distance Visual Acuity (logMAR) With Study Lenses
Day 30, after 6-8 hours of wear
-0.12 logMAR
Standard Deviation 0.07
-0.13 logMAR
Standard Deviation 0.08

Adverse Events

Pretreatment

Serious events: 0 serious events
Other events: 0 other events
Deaths: 0 deaths

LID018869 - Ocular

Serious events: 0 serious events
Other events: 0 other events
Deaths: 0 deaths

LID018869 - Nonocular

Serious events: 0 serious events
Other events: 0 other events
Deaths: 0 deaths

Biofinity - Ocular

Serious events: 0 serious events
Other events: 0 other events
Deaths: 0 deaths

Biofinity - Nonocular

Serious events: 0 serious events
Other events: 0 other events
Deaths: 0 deaths

Serious adverse events

Adverse event data not reported

Other adverse events

Adverse event data not reported

Additional Information

CDMA Project Lead, Vision Care

Alcon Research, LLC

Phone: 1-888-451-3937

Results disclosure agreements

  • Principal investigator is a sponsor employee Sponsor reserves the right of prior review of any publication or presentation of information related to the study.
  • Publication restrictions are in place

Restriction type: OTHER